Alzheimer’s, Gene Therapy & More: Agenda For “What’s Hot” on May 21

Xconomy Boston — 

The gene therapy boom. The frustration of failure after failure in Alzheimer’s disease. The critical interplay between venture firms and “crossover” investors in a volatile, unpredictable macro-environment. The growing need for (and role of) diversity initiatives within the life sciences community—and the personal stories behind them.

These are just some of the topics Xconomy will be featuring this year at our annual half-day forum, “What’s Hot in Boston Biotech,” on May 21 at the Cambridge, MA, offices of Bristol-Myers Squibb (NYSE: BMY). We’ve amassed an eclectic group of speakers and topics in a variety of formats to bring you a unique, personal look at some of the themes that are shaping the biotech world in Boston and beyond. You can get your tickets here.

We’re just putting the finishing touches on the agenda now—here’s a sneak peek. Tickets are going fast but you still have time to grab a discount if you register before May 2. We’ll have more updates as they come—see you on May 21 at Bristol-Myers.